- Enrollment
- 115
- Started
- Jan 2018
- Completion
- Aug 2022
- Locations
- 18
- Countries
- 6
- Updated
- Jun 2021
Industry sponsor intelligence
ObsEva SAClinical Pipeline.
Lead-sponsor view of ObsEva SA's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 0
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 115
Pipeline overview
Programs by phase and activity.
Velocity
ObsEva SA trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 21
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Atosiban → | 1 | 0 | 1 | 0 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All ObsEva SA studies.
This page groups studies where ObsEva SA is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates